Five Key pillars

Our strategy is focused on 5 key pillars, incorporated in our culture and in our dailywork.

  1. Development of a relevant portfolio of biosimilar mAbs through our fully integrated R&D organization and facilities
  2. Inhouse production of Drug Substance and Drug Product in state-of-the-art flexible biomanufacturingfacility
  3. Invest in highest quality and differentiation strategies to develop a value added and patient friendly product
  4. Leverage partnerships through Alvogen alliance and key global and strong local players to bring our high quality biosimilars to patients all around the world
  5. Attract best in class people and experienced leadership team to drive execution

Green energy provides almost

of Iceland’s electricity supply through hydro- and geothermal resources.

Meet us at .
Please tell us a little about yourself.

Meet Us